Unichem Laboratories is currently trading at Rs. 267.25, up by 7.15 points or 2.75% from its previous closing of Rs. 260.10 on the BSE.
The scrip opened at Rs. 259.10 and has touched a high and low of Rs. 277.00 and Rs. 259.10 respectively. So far 7867 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 319.90 on 20-Oct-2016 and a 52 week low of Rs. 239.05 on 30-May-2017.
Last one week high and low of the scrip stood at Rs. 277.00 and Rs. 257.00 respectively. The current market cap of the company is Rs. 2355.77 crore.
The promoters holding in the company stood at 50.08%, while Institutions and Non-Institutions held 16.66% and 33.26% respectively.
Unichem Laboratories’ formulations manufacturing facility at Goa has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA). This receipt indicates the successful closure of the inspection and the queries raised during the audit (Form 483). The inspection has now been closed by the USFDA. The inspection was carried out between March 14, 2017 to March 20, 2017.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
